Free Trial
→ The investigation Porter spent tens of thousands to document (From Porter & Company) (Ad)tc pixel
TSE:OGI

Organigram Q3 2026 Earnings Results & Report

Organigram logo
C$1.15 -0.04 (-3.36%)
As of 11:49 AM Eastern

Organigram reported Q3 2026 earnings on August 11, 2026. The company reported EPS of C$0.77, while revenue was C$105.78 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
Before Market Opens

Organigram EPS Results

Actual EPS
C$0.77
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 8 quarters

Organigram Revenue Results

Actual Revenue
C$105.78 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Organigram Q3 2026 Earnings FAQ

Organigram (TSE:OGI) reported earnings of C$0.77 per share for Q3 2026. The report was announced on Tuesday, August 11, 2026.

Organigram reported revenue of C$105.78 million for Q3 2026.

Organigram Earnings Headlines

Organigram Global Inc. has entered into an arrangement agreement to acquire Aurora Cannabis Inc..
November 4, 2026  |  marketscreener.comM
Organigram (TSE:OGI) Stock Falls 5.9% - Should You Sell?
November 4, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31177232
Uranium Mine Flood That Sparked a 2006 Price Surge Returns
In 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.tc pixel
November 13 at 1:00 AM  |  Digest Publishing (Ad)
Organigram to Acquire Aurora Cannabis for $5.58 a Share
November 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/organigram-acquire-aurora-cannabis-5-145409758.html
Organigram Remains Undervalued After Record-Breaking Quarter
September 10, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4944905-organigram-remains-undervalued-after-record-breaking-quarter
Organigram Global Inc. (OGI:CA) Q3 2026 Earnings Call Transcript
August 11, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4934667-organigram-global-inc-ogi-ca-q3-2026-earnings-call-transcript
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Global Inc. is listed on the NASDAQ Global Select Market and TSX. The Company's wholly owned subsidiary, Organigram Inc., is a licensed cultivator and processor. Through its acquisition of Sanity Group GmbH ('Sanity Group'), Organigram participates in the German medical cannabis market and other emerging markets within Europe. Organigram is focused on producing high-quality cannabis for adult consumers, as well as extending the Company's global footprint. Organigram has also developed and acquired a portfolio of cannabis brands, including Edison, Big Bag O' Buds, SHRED, Monjour, Tremblant, Collective Project, Trailblazer, BOXHOT and DEBUNK. Through its acquisition of Sanity Group, Organigram's European brands include Vayamed, avaay, ZOIKS, Endosane Pharmaceuticals, VAAY, and Grashaus Projects. Organigram operates facilities in Moncton, New Brunswick and Lac Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.

View Organigram Profile
Earnings Tools